Literature DB >> 26505968

The HIV Care Cascade Measured Over Time and by Age, Sex, and Race in a Large National Integrated Care System.

Michael Alan Horberg1,2,3, Leo Bartemeier Hurley3,4, Daniel Benjamin Klein3,5, William James Towner3,6, Peter Kadlecik1,3, Diana Antoniskis3,7, Miguel Mogyoros3,8, Philip Sigmund Brachman3,9, Carol Louise Remmers10, Rebecca Claire Gambatese10, Jackie Blank2,3, Courtney Georgiana Ellis3,4, Michael Jonah Silverberg3,4.   

Abstract

HIV care cascades can evaluate programmatic success over time. However, methodologies for estimating cascade stages vary, and few have evaluated differences by demographic subgroups. We examined cascade performance over time and by age, sex, and race/ethnicity in Kaiser Permanente, providing HIV care in eight US states and Washington, DC. We created cascades for HIV+ members' age ≥13 for 2010-2012. We measured "linkage" (a visit/CD4 within 90 days of being diagnosed for new patients; ≥1 medical visit/year if established); "retention" (≥2 medical visits ≥60 days apart); filled ART (filled ≥3 months of combination ART); and viral suppression (HIV RNA <200 copies/mL last measured in year). The cascades were stratified by calendar year, sex, age, and race/ethnicity. We found men had statistically (p < 0.05) higher percent linkage, filled ART, and viral suppression for 2010 and 2011 but not for 2012. Women had significantly greater retention for all years. Annually, older age was associated (p < 0.05) with retention, filled ART, and viral suppression but not linkage. Latinos had greater (p < 0.05) retention than whites or blacks in all years, with similar retention comparing blacks and whites. Filled ART and viral suppression was increased (p < 0.05) for whites compared with all racial/ethnic groups in all years. Cascade methodology requiring success at upstream stages before measuring success at later stages (i.e., "dependent" methodology) underreported performance by up to 20% compared with evaluating each stage separately ("independent"). Thus, care results improved over time, but significant differences exist by patient demographics. Specifically, retention efforts should be targeted toward younger patients and blacks; women, blacks, and Latinos require greater ART prescribing.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26505968     DOI: 10.1089/apc.2015.0139

Source DB:  PubMed          Journal:  AIDS Patient Care STDS        ISSN: 1087-2914            Impact factor:   5.078


  51 in total

1.  Trends in Racial and Ethnic Disparities in Antiretroviral Therapy Prescription and Viral Suppression in the United States, 2009-2013.

Authors:  Linda Beer; Heather Bradley; Christine L Mattson; Christopher H Johnson; Brooke Hoots; Roy L Shouse
Journal:  J Acquir Immune Defic Syndr       Date:  2016-12-01       Impact factor: 3.731

2.  Comparison of HIV Viral Suppression Between a Sample of Foreign-Born and U.S.-Born Women of Color in the United States.

Authors:  Amanda Nace; Glen Johnson; Elizabeth Eastwood
Journal:  J Immigr Minor Health       Date:  2021-05-11

3.  Healthcare Empowerment and HIV Viral Control: Mediating Roles of Adherence and Retention in Care.

Authors:  Tracey E Wilson; Emma Sophia Kay; Bulent Turan; Mallory O Johnson; Mirjam-Colette Kempf; Janet M Turan; Mardge H Cohen; Adaora A Adimora; Margaret Pereyra; Elizabeth T Golub; Lakshmi Goparaju; Lynn Murchison; Gina M Wingood; Lisa R Metsch
Journal:  Am J Prev Med       Date:  2018-04-12       Impact factor: 5.043

4.  Retention in HIV Care and Viral Suppression: Individual- and Neighborhood-Level Predictors of Racial/Ethnic Differences, Florida, 2015.

Authors:  Diana M Sheehan; Kristopher P Fennie; Daniel E Mauck; Lorene M Maddox; Spencer Lieb; Mary Jo Trepka
Journal:  AIDS Patient Care STDS       Date:  2017-04       Impact factor: 5.078

5.  Completeness of HIV nucleotide sequence ascertainment and its potential impact on understanding HIV transmission - Maryland, 2011-2013.

Authors:  Richard B Brooks; Katherine A Feldman; David Blythe; Colin Flynn
Journal:  AIDS Care       Date:  2018-11-15

6.  Development of a Cascade of Care for responding to the opioid epidemic.

Authors:  Arthur Robin Williams; Edward V Nunes; Adam Bisaga; Frances R Levin; Mark Olfson
Journal:  Am J Drug Alcohol Abuse       Date:  2019-01-24       Impact factor: 3.829

Review 7.  Beyond one pill, once daily: current challenges of antiretroviral therapy management in the United States.

Authors:  Mary Clare Masters; Karen M Krueger; Janna L Williams; Lindsay Morrison; Susan E Cohn
Journal:  Expert Rev Clin Pharmacol       Date:  2019-12       Impact factor: 5.045

8.  Exploring the Healthcare Environment and Associations with Clinical Outcomes of People Living with HIV/AIDS.

Authors:  Mary Hawk; Robert W S Coulter; James E Egan; Mackey Reuel Friedman; Steven Meanley; Stuart Fisk; Courtney Watson; Suzanne Kinsky
Journal:  AIDS Patient Care STDS       Date:  2017-11-17       Impact factor: 5.078

9.  Gender Differences in HIV Testing, Diagnosis, and Linkage to Care in Healthcare Settings: Identifying African American Women with HIV in Chicago.

Authors:  Ellen A Almirol; Moira C McNulty; Jessica Schmitt; Rebecca Eavou; Michelle Taylor; Audra Tobin; Kimberly Ramirez; Nancy Glick; Madison Stamos; Stephanie Schuette; Jessica P Ridgway; David Pitrak
Journal:  AIDS Patient Care STDS       Date:  2018-10       Impact factor: 5.078

10.  Increased antiretroviral therapy prescription and HIV viral suppression among persons receiving clinical care for HIV infection.

Authors:  Heather Bradley; Christine L Mattson; Linda Beer; Ping Huang; R Luke Shouse
Journal:  AIDS       Date:  2016-08-24       Impact factor: 4.177

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.